In Re: Modafinil AntiTrust v.
In Re: Modafinil AntiTrust v.
Opinion
UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT _____________
No. 15-3475 _____________
IN RE: MODAFINIL ANTITRUST LITIGATION
Mylan Laboratories, Inc.; Mylan Pharmaceuticals Inc.; Ranbaxy Laboratories, Ltd; Ranbaxy Pharmaceuticals, Inc., Appellants ______________
On Appeal from the United States District Court for the Eastern District of Pennsylvania District Court No. 2-06-cv-01797 District Judge: The Honorable Mitchell S. Goldberg _________________
Before: SMITH, JORDAN, and RENDELL, Circuit Judges
_________________
ORDER AMENDING OPINION _________________
The opinion filed September 13, 2016 is amended solely as to the listing of Paul
B. Hewitt, Esq. and Catherine Creely, Esq. on the opinion and not as to the substance of
the opinion itself. Mr. Hewitt and Ms. Creely should have been listed as members of
Akin Gump Strauss Hauer & Feld in Washington, DC. Mr. Hewitt was omitted from the
listing of counsel and Ms. Creely was erroneously listed as a member of Cohn & Marks
in Washington, DC. The opinion is amended as follows: Paul B. Hewitt C. Fairley Spillman Catherine E. Creely Akin Gump Strauss Hauer & Feld 1333 New Hampshire Avenue, N.W. Suite 400 Washington, DC 20036
For the Court,
Marcia M. Waldron, Clerk Date: September 29, 2016 PDB/cc: All Counsel of Record
Reference
- Status
- Published